Patent assignee · FR · COMPANY

ADOCIA

🏢 View company profile →
43Patents
42Active
43Granted
53Portfolio score

Filing activity: Mar 31, 2008 → Jan 11, 2022 · 8 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8241620B2 Complex polymere amphiphile-PDGF Human Necessities 13 Active
US9457089B2 Highly concentrated aqueous protein solution with reduced viscosity Human Necessities 13 Active
US9089476B2 Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5 Human Necessities 8 Active
US9493583B2 Anionic polysaccharides functionalized by a hydrophobic acid derivative Chemistry; Metallurgy 8 Active
US9278131B2 Process for lowering the viscosity of highly concentrated protein solutions Human Necessities 5 Active
US8426382B2 Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative Chemistry; Metallurgy 4 Active
US9492467B2 Rapid-acting insulin formulation comprising an oligosaccharide Human Necessities 3 Active
US9700599B2 Rapid-acting insulin formulation comprising a substituted anionic compound Chemistry; Metallurgy 3 Active
US9795678B2 Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound Chemistry; Metallurgy 3 Active
US10646551B2 Rapid-acting insulin formulation comprising a substituted anionic compound Chemistry; Metallurgy 3 Active
US10548952B2 Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Human Necessities 2 Active
US10583175B2 Rapid-acting insulin formulation comprising a substituted anionic compound Chemistry; Metallurgy 2 Active
US10485851B2 Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid Human Necessities 2 Active
US10383918B2 Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acid Human Necessities 2 Active
US10383920B2 Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Human Necessities 2 Active
US8546356B2 Administration form of osteogenic protein complexes Human Necessities 1 Active
US10610572B2 Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action Human Necessities 1 Active
US10881716B2 Rapid-acting insulin formulation comprising a substituted anionic compound Chemistry; Metallurgy 1 Active
US10792335B2 Rapid-acting insulin composition comprising a substituted citrate Human Necessities 1 Active
US11191812B2 Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid Human Necessities 1 Active
US8367640B2 Complex consisted of a polysaccharide and an HBP Human Necessities 1 Active
US9018190B2 Functionalized oligosaccharides Chemistry; Metallurgy 1 Active
US8389661B2 Complexes between an amphiphilic polymer and an osteogenic protein belonging to the family of BMPs Chemistry; Metallurgy 1 Active
US11633460B2 Injectable solution at pH 7 comprising at least one basal insulin wherein the pI is comprised from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Chemistry; Metallurgy 1 Active
US8669227B2 Fast-acting insulin formulation Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.